2 weeks Ago By Defense World Staff
Envestnet Portfolio Solutions Inc. trimmed its position in Chemed Co. ( NYSE:CHE – Free Report ) by 2.
5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,268 shares of the company’s stock after selling 33 shares during the quarter. Envestnet Portfolio Solutions Inc.
’s holdings in Chemed were worth $672,000 as of its most recent SEC filing. Other institutional investors have also recently modified their holdings of the company. Pathstone Holdings LLC raised its position in Chemed by 6.
0% during the 3rd quarter. Pathstone Holdings LLC now owns 3,694 shares of the company’s stock worth $2,220,000 after buying an additional 210 shares during the last quarter. B.
Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Chemed during the third quarter worth $310,000.
Charles Schwab Investment Management Inc. lifted its position in Chemed by 8.1% during the third quarter.
Charles Schwab Investment Management Inc. now owns 122,788 shares of the company’s stock valued at $73,792,000 after purchasing an additional 9,178 shares during the period. Cerity Partners LLC boosted its holdings in Chemed by 30.
8% in the third quarter. Cerity Partners LLC now owns 849 shares of the company’s stock valued at $510,000 after purchasing an additional 200 shares during the last quarter. Finally, Loomis Sayles & Co.
L P grew its position in Chemed by 0.4% during the 3rd quarter. Loomis Sayles & Co.
L P now owns 29,159 shares of the company’s stock worth $17,523,000 after purchasing an additional 108 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth A number of analysts have recently commented on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.
Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.
Chemed Stock Up 2.2 % CHE stock opened at $606.93 on Tuesday.
Chemed Co. has a 52-week low of $512.12 and a 52-week high of $648.
29. The firm has a market cap of $8.88 billion, a P/E ratio of 30.
67, a PEG ratio of 2.15 and a beta of 0.43.
The company’s 50-day simple moving average is $569.25 and its 200-day simple moving average is $565.58.
Chemed Dividend Announcement The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a dividend of $0.50 per share.
This represents a $2.00 annualized dividend and a dividend yield of 0.33%.
The ex-dividend date of this dividend was Monday, February 24th. Chemed’s payout ratio is 10.05%.
Insiders Place Their Bets In other Chemed news, VP Brian C. Judkins bought 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was acquired at an average cost of $519.
50 per share, for a total transaction of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares of the company’s stock, valued at approximately $871,721.
This represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link .
Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.
67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.
93. This represents a 1.91 % decrease in their ownership of the stock.
The disclosure for this sale can be found here . 3.32% of the stock is currently owned by company insiders.
Chemed Company Profile ( Free Report ) Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles Five stocks we like better than Chemed Stock Trading Terms – Stock Terms Every Investor Needs to Know Super Micro Stock: $7.2M Call Options Signal Big Upside Potential How to Use the MarketBeat Stock Screener Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch What is the Nikkei 225 index? D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst? Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter .
.
